USP18 Antibody [A22C11]

Catalog No.: F4648

    Application: Reactivity:
    • Lane 1: RAW 264.7, Lane 2: RAW 264.7 (LPS, 1 µg/mL, 24 h)
    1/

    当該製品は品切れ状态で、ごメールアドレスを教えていただければ、在庫があると、メールで顧客様に伝えます。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    使用情報

    Dilution
    1:1000
    1:50
    1:800 - 1:1600
    Application
    WB, IP, IF
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Mouse
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW
    40 kDa

    Datasheet & SDS

    生物学的記述

    Specificity
    USP18 (E9K4X) Rabbit mAb detects endogenous levels of total USP18 protein.
    Clone
    A22C11
    Synonym(s)
    Ubl carboxyl-terminal hydrolase 18; 43 kDa ISG15-specific protease (hUBP43); ISG15-specific-processing protease; Ubl thioesterase 18; USP18; ISG43
    Background
    USP18 (Ubiquitin-Specific Protease 18, also known as UBP43) is a key deubiquitinating enzyme that specifically removes ISG15 from conjugated target proteins, thereby regulating the cellular ISGylation state essential for antiviral immunity and immune homeostasis. USP18 features the canonical USP fold with finger, palm, and thumb domains, including a zinc-coordinated finger domain for structural integrity and a catalytic triad mediating its isopeptidase activity. USP18 acts as a critical negative regulator of type I interferon signaling by binding to the IFNAR2 subunit of the interferon receptor and blocking JAK1 recruitment and STAT phosphorylation, thus preventing excessive interferon-driven inflammation and autoimmunity. USP18 expression is upregulated by interferons and inflammatory cues, serving as a feedback inhibitor that balances robust antiviral responses with immune regulation. Dysregulation of USP18 is implicated in autoimmune diseases, cancer progression, and altered therapeutic outcomes.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください